HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Nyctometric studies in argon laser coagulation in patients with diabetic retinopathy]

AbstractForty-two patients (57 eyes) with diabetic retinopathy at various stages have been examined by nyctometry before and over the course of the follow-up period after argon laser coagulation of the retina. The findings evidence a marked reduction of the adaptation ability of the central retinal area even in high vision acuity in the patients with diabetic retinopathy vs. normal subjects. A stable rise of the nyctometric parameters has been observed after argon laser coagulation; these parameters characterize the function of the pigmented epithelium and of the retinal cone, and these data may be considered as an evidence of the improved trophics of these tissues, resultant from such therapy.
AuthorsZ M Mironova, F A Romashenkov, O A Pliukhova, N B Doctor, A N Bessarabov
JournalVestnik oftalmologii (Vestn Oftalmol) 1989 May-Jun Vol. 105 Issue 3 Pg. 30-2 ISSN: 0042-465X [Print] USSR
Vernacular TitleNiktometricheskie issledovaniia pri argonovoĭ lazerkoaguliatsii u bol'nykh s diabeticheskoĭ retinopatieĭ.
PMID2749968 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Adult
  • Dark Adaptation
  • Diabetic Retinopathy (physiopathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Light Coagulation
  • Male
  • Middle Aged
  • Photoreceptor Cells (physiopathology)
  • Pigment Epithelium of Eye (physiopathology)
  • Retina (surgery)
  • Time Factors
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD